Can a coated Dacron vascular graft maintain a heparin-induced thrombocytopenia type II?

Langenbecks Arch Surg. 2001 Jul;386(4):267-71. doi: 10.1007/s004230100213.

Abstract

In the course of reconstruction of peripheral arterial occlusion processes, two gelatin-coated Dacron grafts and one collagen-coated Dacron patch were implanted in a 52-year-old male patient. Eight days following low-dose heparinization (5 days prior to surgery, 3 days postoperatively) with unfractionated heparin, with no clinical symptoms present, a dramatic isolated thrombocyte depression occurred, from 212 Gpt/l prior to surgery to 14 Gpt/l on postoperative day 3. Laboratory tests verified an HIT type II [heparin-induced platelet aggregation assay (HIPAA) and ELISA]. Despite immediate discontinuation of heparin and commencement of an anticoagulant therapy with Revasc and Refludan, an 8-week thrombocyte depression occurred which was eliminated only temporarily by administration of gammaglobulin. The specific antibody tests turned out positive for more than 5 months. Having ruled out other causes of thrombocytopenia, we assume that the case presented was either due to an interaction not elucidated to date or triggered by the grafts (gelatin/collagen/Dacron). The manufacturers of the grafts have disputed a heparinoid action.

Publication types

  • Case Reports

MeSH terms

  • Arterial Occlusive Diseases / surgery*
  • Blood Vessel Prosthesis / adverse effects*
  • Coated Materials, Biocompatible
  • Collagen
  • Diagnosis, Differential
  • Enzyme-Linked Immunosorbent Assay
  • Gelatin
  • Heparin / administration & dosage
  • Heparin / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Polyethylene Terephthalates / adverse effects*
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / prevention & control

Substances

  • Coated Materials, Biocompatible
  • Polyethylene Terephthalates
  • Gelatin
  • Heparin
  • Collagen